Leadership

Norman E. Sharpless, MD, director of the National Cancer Institute (NCI) since October 2017, has been announced as the new acting commissioner of the FDA. Sharpless replaces Scott Gottlieb, MD, who unexpectedly resigned from the position on March 5.

FDA Commissioner Scott Gottlieb is resigning. Gottlieb has manned the agency since May 2017 and will leave his position in about a month.